UBS Group’s Telix Pharmaceuticals Limited American Depositary Shares TLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$98.4K	Buy	6,121 +2,470	+68%	+$39.7K	﹤0.01%	5991
2025 Q1	$61.2K	Sell	3,651 -79	-2%	-$1.32K	﹤0.01%	6148
2024 Q4	$57.4K	Buy	+3,730	New	+$57.4K	﹤0.01%	5995